Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 50 of 138 Next >>

Filter Applied: adverse drug reaction (Click to remove)

Vitamin B12 Deficiency:NICE Guideline Summary
BMJ 385:q1019, q1262, Sands,T.,et al, 2024

A 54-year-old woman with Dementia, Myoclonus, and Ataxia
Neurol 89:e7-e12, Ali, F.,et al, 2017

A 60-Year-Old Woman with Mild Memory Impairment: Review of Mild Cognitive Impairment
JAMA 300:1566-1574,1598, Ellison,J.M., 2008

Treatment-Induced Leukoencephalopathy in Primary CNS Lymphoma,A Clinical and Autopsy Study
Neurol 62:451-456, Lai,R.,et al, 2004

Sibutramine May Be Associated With Memory Impairment
BMJ 329:1316, Clark,D.W.J. &Harrison-Woolrych,M., 2004

Intoxication with Riluzole in Huntington's Diease
Neurol 57:1141-1143, Bodner,Th.,et al, 2001

The Effect on Memory of Chronic Prednisone Treatment in Patients with Systemic Disease
Neurol 47:1396-1402, Keenan,P.A.,et al, 1996

Next-Day Memory Impairment with Triazolam Use
Lancet 337:827-831, Bixler,E.O.,et al, 1991

Cognitive Impairment Associated with Beta-Blockade in the Elderly
Postgrad Med J 66:1050-1052, Rogers,T.K.&Bowman,C.E., 1990

Drug-Induced Alzheimerism
Arch Neurol 45:356-357, Kurlan,R.&Como,P., 1988

Muscular Dystrophies
Lancet 394:2025-2038, Mercuri, E.,et al, 2019

Parkinsons Disease
Lancet 373:2055-2066, Lees,A.J.,et al, 2009

Ximelagatran--Promises and Concerns
JAMA 293:736-739, Gurewich,V., 2005

Parkinson's Disease
NEJM 339:1044-1053,1130-1143, Lang,A.E.&Lozano,A.M., 1998

Severe Myotonic Crisis Resembling Malignant Hyperthermia
Neurol 104:e213497, Wadhwani,A.R.,et al, 2025

AAV9-Mediated Gene Therapy for Infantile-Onset Pompes Disease
NEJM 392:2438-2446, 2477, Ma,X.,et al, 2025

Chronic Immunotherapy for Myasthenia Gravis
www.UptoDate.Com, Bird,S.J., 2024

Posterior Reversible Encephalopathy Syndrome
NEJM 388:2171-2178, Geocadin,R.G., 2023

Migraine
NEJM 383:1866-1876, Ashina, M., 2020

Looking Beyond the Usual
Delhi J Ophthal doi:7869/djo.555, Shakrawal, J.,et al, 2020

Antiepileptic Drug Treatment Patterns in Women of Childbearing Age with Epilepsy
JAMA Neurol 76:783-790, Kim, H.,et al, 2019

Risk of 23 Specific Malformations Associated with Prenatal Exposure to 10 Antiepileptic Drugs
Neurol 93:e167-e180, Blotiere, P.O.,et al, 2019

Acute coronary syndrome associated with alemtuzumab infusion in multiple sclerosis
Neruol 90:852-854, Ferraro, D.,et al, 2018

Factor Xa Inhibitors Versus Vitamin K Antagonists for Prevention of Cerebral or Systemic Embolism in Patients with Atrial Fibrillation
Stroke 49:e235-e236, Bruins Slot, K.M.H. & Berge, E., 2018

Pregabalin Use Early in Pregnancy and the Risk of Major Congenital Malformations
Neurol 88:2020-2025, Patorno, E.,et al, 2017

Maternal Use of antiepileptic Agents During Pregnancy and Major Congenital Malformations in Children
JAMA 318:1700-1701, Bromley, R.L.,et al, 2017

Oral Anticoagulants for Prevention of Stroke in Atrial Fibrillation: Systematic Review, Network Meta-Analysis, and Cost Effectiveness Analysis
BMJ 359:J5058, Lopez-Lopez, J.A.,et al, 2017

Newer Agents in the Treatment of Multiple Sclerosis
Neurologist 19:104-117, Pawate, S. & Bagnato F., 2015

Ischemic Optic Neuropathies
NEJM 372:2428-2436, Biousse, V. & Newman, N.J., 2015

Dystonia in Children and Adolescents: A Systematic Review and a New Diagnostic Algorithm
JNNP 86:774-781, Van Egmond, M.E.,et al, 2015

Cardiovascular Dysfunction in Multiple Sclerosis
Neurologist 20:108-114, Kaplan, T.B.,et al, 2015

Stroke and Recurrent Haemorrhage Associated with Antithrombotic Treatment after Gastrointestinal Bleeding in Patients with Atrial Fibrillation: Nationwide Cohort Study
BMJ 351:h5876, h6104, Staerk, L.,et al, 2015

Effect of Citalopram on Agitation in Alzheimer Disease The CitAD Randomized Clinical Trial
JAMA 311:682-691, Porsteinsson, A.P.,et al, 2014

Rethinking Warfarin for Atrial Fibrillation
JAMA 311:1246, Zuccott, G & Pflomm, J.M., 2014

Hormone Replacement Therapy and Adverse Outcomes in Women with Atrial Fibrillation
Stroke 45:3076-3079, Apostolakis, S.,et al, 2014

The Acquired Metabolic Disorders of the Nervous System, Hyperglycemia
Adams & Victors Principles of Neurology Chp 40, pg 1141, Ropper, A.H.,et al, 2014

Disturbances of Cerebrospinal Fluid, Including Hydrocephalus, Pseudotumor Cerebri, and Low-Pressure Syndromes, Pseudotumor Cerebri
Adams & Victors Principles of Neurology, Chp 30, pg 628, Ropper, A.H.,et al, 2014

Using Dabigatran in Patients with Stroke A Practical Guide for Clinicians
Stroke 43:271-279, Alberts, M.J.,et al, 2012

New Antithrombotic Drugs for Atrial Fibrillation: Caution is Needed
Lancet 379:e24, Bell,S.,et al, 2012

Anticoagulant Loses its Lustre
Lancet 379:301, Mullar,A., 2012

Apixaban in Patients With Atrial Fibrillation
NEJM 364:806-817, Connolly,S.J.,et al, 2011

Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data
Pharmacol Ther 129:185-194, Terry, K.W.,et al, 2011

Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study
BMJ 343:d3450, Schmidt, M.,et al, 2011

Fetal Effects of Anticonvulsant Polytherapies
Arch Neurol 68:1273-1279, Holmes, L.et al, 2011

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
NEJM 362:387-401, 456, Kappos, L.,et al, 2010

Dabigatran Challenges Warfarins Superiority for Stroke Prevention in Atrial Fibrillation
Stroke 41:1307-1309, Schwartz,N.E. &Albers,G.W., 2010

Prolactinomas
NEJM 362:1219-1226, Klibanski,A., 2010

Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations
NEJM 362:2185-2193, Jentink,J., et al, 2010

Quality of Anticoagulation Control in Atrial Fibrillation
Lancet 376:935-937, Lane,D.A. &Lip,G.Y.H., 2010



Showing articles 0 to 50 of 138 Next >>